Earnings Feed
Start Free
Edesa Biotech, Inc.·4

Mar 6, 5:01 PM ET

Nijhawan Pardeep 4

Research Summary

AI-generated summary

Updated

Edesa Biotech (EDSA) CEO Pardeep Nijhawan Buys 10,000 Shares

What Happened

  • Pardeep Nijhawan, CEO of Edesa Biotech (EDSA), reported a purchase of 10,000 shares on 2026-03-05. The shares were acquired at $3.90 each for a total reported cost of $39,000. The transaction is coded P (purchase), which is a direct buy rather than a sale or option exercise.

Key Details

  • Transaction date: 2026-03-05; Filing date: 2026-03-06 (filed the next day).
  • Price and amount: 10,000 shares at $3.90 per share; total $39,000.
  • Shares owned after transaction: not specified in the provided filing details.
  • Footnotes:
    • F1: Some reported shares are held by entities wholly owned by Nijhawan (Pardeep Medicine Professional Corp., The Digestive Health Clinic Inc., and 1968160 Ontario Inc.); he disclaims beneficial ownership except to the extent of his pecuniary interest.
    • F2: He is co-trustee of The New Nijhawan Family Trust 2015 and similarly disclaims beneficial ownership except to the extent of pecuniary interest.
  • No 10b5-1 trading plan, tax-withholding sale, or option exercise was indicated in the report.

Context

  • Purchases by executives can be viewed as a positive signal since they increase the insider's stake, but filings do not disclose the insider's motivation. This filing appears timely (filed within one day of the trade).